Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$143.93 - $224.51 $8.48 Million - $13.2 Million
58,900 New
58,900 $13.2 Million
Q4 2023

Feb 14, 2024

SELL
$158.67 - $201.58 $1.09 Million - $1.39 Million
-6,900 Reduced 47.92%
7,500 $1.35 Million
Q3 2023

Nov 14, 2023

BUY
$179.87 - $225.13 $2.59 Million - $3.24 Million
14,400 New
14,400 $2.59 Million
Q1 2023

May 15, 2023

BUY
$215.53 - $274.5 $387,954 - $494,100
1,800 Added 12.0%
16,800 $3.62 Million
Q4 2022

Feb 14, 2023

BUY
$125.51 - $229.3 $1.46 Million - $2.66 Million
11,600 Added 341.18%
15,000 $3.3 Million
Q3 2022

Nov 14, 2022

SELL
$131.8 - $202.24 $1.53 Million - $2.35 Million
-11,600 Reduced 77.33%
3,400 $458,000
Q4 2021

Feb 11, 2022

SELL
$248.56 - $389.34 $4.97 Million - $7.79 Million
-20,000 Reduced 57.14%
15,000 $4.06 Million
Q3 2021

Nov 12, 2021

BUY
$249.6 - $403.14 $3.74 Million - $6.05 Million
15,000 Added 75.0%
35,000 $12.7 Million
Q2 2021

Aug 16, 2021

BUY
$292.75 - $367.01 $5.86 Million - $7.34 Million
20,000 New
20,000 $6.86 Million
Q4 2020

Feb 16, 2021

SELL
$221.31 - $316.61 $2.32 Million - $3.32 Million
-10,500 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$189.18 - $286.44 $1.99 Million - $3.01 Million
10,500 New
10,500 $3.01 Million
Q1 2020

May 15, 2020

SELL
$121.84 - $173.19 $1.1 Million - $1.56 Million
-9,000 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$115.78 - $208.34 $1.04 Million - $1.88 Million
9,000 New
9,000 $1.49 Million

Others Institutions Holding BGNE

About BeiGene, Ltd.


  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $18.6B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.